Coronavirus: When does the Merck pill and the monoclonal antibodies “come” to Greece?
During the information from the Ministry of Health about the course of the pandemic, which records dangerous outbreakMs. Gaga emphasized, however, that with regard to coronavirus medications, the offers would be such that they clearly could not cover all patients and the vaccination remains absolutely necessary for protection against Covid-19.
“We have 6,800 new cases of coronavirus every day and the drugs we have are in the range of 2,000-10,000 up there, not 100,000,” she said when asked about alternate health.
So, he pointed out that it is clear that not everyone can get it and it is much safer to be vaccinated – “much safer to prevent cases than to cure”.
“We will bring the drugs into processes, and through bilateral agreements, and through Europe, but there is no such production that deals with the cases we have at the moment,” Ms. Gaga noted.
He added that we must wear masks, not synchronize and test frequently to stop the pandemic.
As for medication schedule, Mina Gaga specifically stated that the treatment based on monoclonal antibodies exists “within the next few weeks”, while regarding Merck pills she stated that “we are in consultation with the company so that we can import”.
EMA: The way is open for the use of Merck antiviral pill
The European Medicines Agency (EMA) has already stated ready to recommend in the Member States of the Union on use for emergency of the antiviral pill against Covid-19, co-developed by Merck and Ridgeback Biotherapeutics, received earlier today, Thursday, received approval in the United Kingdom.
“We will try to speed up our evaluation in order to get approval as soon as possible,” he said in a press conference. Marco Cavaleri, head of vaccine strategy at EMA, adding that he can not yet give an exact date.
“We are ready to recommend to EU Member States that they do not have access to this new oral emergency pill before it is approved,” he said.
THE Britain was done today the first country in the world approved of the active substance molnupiravir should be used as soon as possible after diagnosis of a patient with Covid-19 and in five days after the onset of symptoms, in a development that may change the course of the pandemic.
These are the first anti-Covid words available on the market.
The specific treatment halves the risk of hospitalization, according to a clinical trial by Merck.
The EMA has once again urged the population to be vaccinated as soon as possible in the face of a “fourth wave” of the pandemic affecting the continent.
THE World Health Organisation At the same time, the alarm bell rang earlier today for the “very worrying” transmission rate of Covid-19 in Europe, which could cause half a million extra deaths on the continent from now until February.
“Bell” WHO for the outbreak of coronavirus in Europe